Chun-Liang Lai

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Chao‐Hua Chiu, Cheng‐Ta Yang, Jin‐Yuan Shih et al. · Journal of Thoracic Oncology · 2015 · 245 citations

Medicine, Oncology, Pharmacology +14

Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma

Wen-Wei Huang, Shih‐Ming Tsao, Chun-Liang Lai et al. · Pathology · 2010 · 42 citations

Medicine, Oncology, Pathology +17

Antagonism between Gefitinib and Cisplatin in Non-small Cell Lung Cancer Cells: Why Randomized Trials Failed?

Chun-Ming Tsai, Jen-Ting Chen, David J. Stewart et al. · Journal of Thoracic Oncology · 2011 · 36 citations · Full text

Medicine, Oncology, Pharmacology +13

Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study

Wen-Chien Fan, Chong‐Jen Yu, Chun-Ming Tsai et al. · Journal of Thoracic Oncology · 2010 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Gefitinib Enhances Cytotoxicities of Antimicrotubule Agents in Non–Small-Cell Lung Cancer Cells Exhibiting No Sensitizing Epidermal Growth Factor Receptor Mutation

Chun-Ming Tsai, Chao‐Hua Chiu, Kao-Ting Chang et al. · Journal of Thoracic Oncology · 2012 · 24 citations

Medicine, Oncology, Pharmacology +12